What does the CDC recommend for preventing Chlamydia in high-risk groups?
To prevent the spread of chlamydia, particularly among groups at higher risk for sexually transmitted infections (STIs), the CDC provides specific guidelines involving medication and screening protocols.
What the research says
The CDC recommends using doxycycline as postexposure prophylaxis (PEP) to help reduce the number of cases of syphilis, chlamydia, and gonorrhea in populations identified as high-risk 4. Research indicates that doxycycline is an effective tool for this purpose; a meta-analysis showed that doxycycline prophylaxis reduced the risk of acquiring chlamydia by approximately 76% in certain study groups 3.
In addition to prevention through medication, specific screening protocols are used to identify and manage infections. For example, the CDC recommends universal chlamydia screening at intake for all females in juvenile detention facilities because even those without known risk factors can have a high rate of infection 6. Furthermore, while not recommended for the general population, the CDC does recommend extragenital screening (testing sites other than the genitals) for men who have sex with men to better identify infections 7.
What to ask your doctor
- Am I in a high-risk group that qualifies for doxycycline postexposure prophylaxis (PEP)?
- What are the specific risks of chlamydia for my demographic?
- Are there specific screening tests recommended based on my sexual history or behaviors?
- How often should I be screened for chlamydia and other STIs?
This question is drawn from common patient questions about Infectious Disease and answered using cited medical research. We do not provide individualized advice.